| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely amprenavir 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely amprenavir 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely alverine citrate 120 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Alverine citrate 60 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely nizatidine 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Nizatidine 300 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Omeprazole 40 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Omeprazole 10 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Olsalazine sodium 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Balsalazide disodium 750 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Orlistat 120 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Mexiletine hydrochloride 50 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely mexiletine hydrochloride 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely acebutolol 100 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely acebutolol 200 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
| Methyldopa 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely metirosine 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely nicardipine hydrochloride 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Nicardipine hydrochloride 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely nifedipine 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Nifedipine 10 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely naftidrofuryl oxalate 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Acipimox 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Carbocisteine 375 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely clomethiazole 192 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlordiazepoxide hydrochloride 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlordiazepoxide hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely amobarbital sodium 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Amobarbital sodium 60 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Haloperidol 500 microgram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely nabilone 1 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Hydromorphone hydrochloride 1.3 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Hydromorphone hydrochloride 2.6 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely amantadine hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Amoxicillin 500 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ampicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ampicillin 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ampicillin 250 milligram and flucloxacillin 250 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ampicillin 250 milligram and flucloxacillin 250 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cefaclor 500 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefadroxil 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefalexin monohydrate 500 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefradine 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cefradine 500 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely minocycline 50 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely minocycline 100 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely azithromycin (as azithromycin dihydrate) 250 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Chloramphenicol 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely nitrofurantoin 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Nitrofurantoin 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Bromocriptine (as bromocriptine mesilate) 10 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Bromocriptine (as bromocriptine mesilate) 5 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Metyrapone 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydroxycarbamide 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely altretamine 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Mycophenolate mofetil 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Alfacalcidol 250 nanogram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Alfacalcidol 1 microgram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Alfacalcidol 500 nanogram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely calcitriol 250 nanogram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely calcitriol 500 nanogram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely alpha tocopherol acetate 75 international unit/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely alpha tocopherol acetate 200 international unit/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely alpha tocopherol acetate 400 international unit/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely mercaptamine (as mercaptamine bitartrate) 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely mercaptamine (as mercaptamine bitartrate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely azapropazone 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely acemetacin 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Celecoxib 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely celecoxib 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Acitretin 10 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Acitretin 25 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Simeticone 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftibuten 400 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely novobiocin sodium 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
3 |
| Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
4 |
| Product containing precisely calcium acetate 667 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Calcium acetate 333.5 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlordiazepoxide hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely nitrofurantoin 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely acebutolol hydrochloride 400 milligram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Aciclovir 200 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 375 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Benzonatate 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorphenamine 12 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely anagrelide hydrochloride 500 microgram/1 each conventional release oral capsule |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
FHIR